<DOC>
	<DOCNO>NCT00251693</DOCNO>
	<brief_summary>The purpose study assess efficacy safety 8 week once-daily ( QD ) treatment dexlansoprazole modify release ( MR ) 60 mg 90 mg lansoprazole 30 mg heal subject endoscopically proven erosive esophagitis .</brief_summary>
	<brief_title>Efficacy Safety Dexlansoprazole MR Lansoprazole Healing Erosive Esophagitis</brief_title>
	<detailed_description>This Phase 3 , randomize , double-blind , multi-center , active-controlled , 3-arm study 8-week treatment period . This study compare efficacy dexlansoprazole MR ( 60 mg QD 90 mg QD ) lansoprazole ( 30 mg ) administer orally single daily dose morning , breakfast . The study design evaluate healing erosive esophagitis effect therapy relieve gastroesophageal reflux disease-related symptom . The study consist two period , screen period ( maximum 21 day ) treatment period , last 8 week .</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis , Peptic</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>Subject must endoscopically confirm erosive esophagitis define Los Angeles ( LA ) Classification Grading System ( AD ) Subject positive Campylobacterlike organism ( CLO ) test Helicobacter ( H. ) pylorus . Use prescription nonprescription proton pump inhibitor ( PPIs ) , histamine ( H2 ) receptor antagonist sucralfate , drug significant anticholinergic effect , misoprostol prokinetics Use antacid [ except study supply GelusilÂ® ] Need continuous anticoagulant therapy ( blood thinner ) Endoscopic Barrett 's esophagus and/or definite dysplastic change esophagus History dilatation esophageal stricture , Schatzki 's ring ( ring mucosal tissue near low esophageal sphincter ) Current historical evidence ZollingerEllison syndrome hypersecretory condition . History gastric , duodenal esophageal surgery except simple oversew ulcer . Acute upper gastrointestinal hemorrhage within 4 week screen endoscopy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Erosive Esophagitis</keyword>
</DOC>